Abstract
Background: Anatomic complexity is a challenge for radiation oncologist.Repeated CT scans and replanning can
overcome the variations in terms of size or shape a tumour has undergone during treatment , this process has been termed
as Adaptive Radiotherapy(ART). The use of adaptive approach or IMRT-SIB is still under debate since there is not enough evidence of long-term
clinical outcomes , metastasis free survival. Total Sixty patients Materials And Methods: with locally advanced HNC with a intent to cure were
assigned into two arms to receive IMRT up to a dose of 70 Gy with concurrent weekly chemotherapy and were prospectively analyzed between
March 2018 and March 2019. Repeat CT scan was acquired after the 3rd week of radiation and those in the study arm were replannned and those
in the controlarm continued with the rst IMRT plan. For the entire cohort, patients were assessed weekly till the end of treatment and at 1, 3, and6
months, 1 year and 2 years thereafter. Main focus was on Xerostomia status at end of 6 months and end of 2 years and Survival (OS) rates at end of
2-years was calculated and hence compared. 2 years overall survival rate wa Results: s almost similar with 73.33% vs 76.66% in adaptive
IMRTand conventional IMRT respectively; p value= 0. 23 Xerostomia was statistically signicantly higher in the conventional arm at 6
months(p=0.01).Grade ≥II xerostomia at end of 2 years reduced to 0% vs 4.43 %in adaptive and conventional IMRT respectively (p= 0.78).
Conclusion: Adaptive IMRT can help to minimise xerostomia at end of 6 months .However no major benet in survival when compared 2 year
after completion of treatment.
Subject
General Nursing,Education,General Nursing,General Medicine,Ophthalmology,Religious studies,Pharmacology (medical),Geometry and Topology,Algebra and Number Theory,Economics and Econometrics,Industrial relations,Management of Technology and Innovation,Organizational Behavior and Human Resource Management,Strategy and Management,General Medicine,Pathology and Forensic Medicine
Reference20 articles.
1. Parkin DM, Bray F, Ferlay J, Pisani P. Global Cancer Statistics, 2002. CA Cancer J Clin 2005;55:74‑108.
2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394‑424.
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893‑917.
4. Kekatpure V, Kuriakose MA. Oral Cancer in India: Learning From Different Populations. National Newsletter and Website from New York Presbyterian Hospital; 2010. Available from: http://www. nypcancerprevention.com/issue/14/cancer_prevention/feature/india. shtml. [Last accessed on 2019 Oct 10].
5. National Cancer Registry Programme. Consolidated Report of the Population Based Cancer Registries. 1990‑1996. New Delhi: Indian Council of Medical Research